Interesting! Below a post from a member on "Investors Hub"
At home clinical trial confirmed. I was talking about this possibility in previous posts but now see it is on the clinical trial info, This may be the first at home Covid phase 3 trial.
From the clinical trial website:
Quote:
Patients qualifying for study enrollment will initiate therapy as outpatients, under home quarantine. Patients will receive continued standard care of therapy (per study site written policies or guidelines) together with bucillamine and/ or matching placebo for up to 14 days. Dosing should continue until the treatment course is completed or as medically indicated (e.g., deterioration of clinical status and alternative therapy required). If the patient requires hospitalization during the study period, treatment will be discontinued.
This Is the real deal. Other therapeutics are for people in critical condition but Bucillamine will be a take home therapy. Many more patients in this category of mild-moderate and much more revenue will be made vs other therapeutics. They even mention that hospitalized patients will be disqualified (I think once you are hospitalized you are not considered mild-moderate anymore)
This is a whole new market of therapeutics that does not overlap with the other big therapeutics that are treating people in hospital If this is approved it will be stocked at every pharmacy in North America. Other big therapeutics (infusions and shots) are going to be administered in hospitals only and will not see the same volume of sales.
This could be similar to Tamiflu For influenza which sees $277 million in sales last year.